Prosight Management LP 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 4:23 pm Purchase | 2026-02-03 | 13G | JANUX THERAPEUTICS INC JANX | Prosight Management LP | 3,157,220 5.300% | 3,157,220 (New Position) | Filing |